Parenteral Nutrition Market Size, Share & Forecast Report - 2026 to 2030

The global parenteral nutrition market size was valued at over USD 7 billion in 2024 and estimated to register a significant CAGR of around 6% during the forecast period from 2025 to 2030. Clinical nutrition is critical to combating malnutrition during hospitalization and the rising prevalence of chronic diseases around the world is a major factor to drive the market growth. Furthermore, the rapid growth in the geriatric population and the increasing expenditure on healthcare is further expected to fuel the market over the forecast period from 2021 to 2027. Moreover, the increasing demand for low-cost parenteral nutrition and the growing popularity of intravenous vitamin C is projected to propel the market.

Market Snapshot::

Emerging Trends Shaping the Parenteral Nutrition Market:

The parenteral nutrition market is witnessing strong growth trends driven by the rising prevalence of chronic diseases such as cancer, gastrointestinal disorders, and malnutrition that impair normal food absorption. With the global increase in the aging population, demand for parenteral nutrition is surging, as elderly patients are more prone to chronic illnesses and require specialized nutrition support. Additionally, the growing number of preterm births, particularly in developing regions, has accelerated the adoption of parenteral nutrition solutions to provide vital nutrients for neonatal care. Hospitals and specialized clinics are increasingly integrating advanced parenteral nutrition therapies, reflecting a shift toward personalized formulations tailored to patient-specific needs.

Another key trend is the advancement in parenteral nutrition formulations and delivery technologies. Innovations in lipid emulsions, amino acid solutions, and multivitamin formulations are helping reduce side effects while improving patient outcomes. The market is also influenced by the adoption of multi-chamber bags and ready-to-use parenteral solutions, which improve convenience, reduce preparation errors, and enhance patient safety. Furthermore, the shift toward home-based parenteral nutrition, supported by improved infusion pumps and monitoring systems, is gaining traction, particularly in developed regions. These advancements, coupled with increasing healthcare spending and supportive government initiatives, are shaping the future growth trajectory of the parenteral nutrition market.

Parenteral Nutrition Market Key Drivers:

• Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as cancer, gastrointestinal disorders, and malnutrition drives the demand for parenteral nutrition. Patients with these conditions often require specialized nutrition support when they are unable to consume food orally or absorb nutrients adequately through the gastrointestinal tract.
• Growing Aging Population: The aging population is a significant driver of the parenteral nutrition market. Elderly individuals often face medical conditions that impact their ability to eat or absorb nutrients, necessitating the use of parenteral nutrition as a source of essential nutrients.
• Hospitalization and Critical Care: Parenteral nutrition plays a vital role in the management of critically ill patients and those undergoing major surgeries who cannot receive adequate nutrition orally. Hospitalizations and critical care scenarios, where patients require intravenous feeding, contribute to the demand for parenteral nutrition.
• Technological Advancements and Product Innovations: Advances in parenteral nutrition formulations, delivery systems, and compounding techniques have improved the safety, efficacy, and convenience of these products. Technological innovations, such as ready-to-use premixed parenteral nutrition solutions and advanced infusion pumps, drive market growth.
• Increasing Awareness about Clinical Nutrition: There is growing awareness among healthcare professionals about the importance of optimal nutrition in patient care. The recognition of the impact of nutrition on patient outcomes has led to an increased emphasis on providing appropriate nutrition support, including parenteral nutrition, in various healthcare settings.
• Homecare Settings and Ambulatory Infusion: The shift towards home-based healthcare and ambulatory infusion services has expanded the use of parenteral nutrition outside of traditional hospital settings. This trend allows patients to receive parenteral nutrition in the comfort of their homes, contributing to market growth.
• Complex Gastrointestinal Surgeries: Gastrointestinal surgeries, such as bowel resections and bypass procedures, often result in temporary or permanent malabsorption of nutrients. Parenteral nutrition plays a crucial role in supporting patients during the recovery phase, promoting wound healing and minimizing the risk of malnutrition.
• Nutritional Support in Pediatric Patients: Pediatric patients with congenital disorders, gastrointestinal diseases, or inadequate oral intake may require parenteral nutrition to meet their nutritional needs. The demand for parenteral nutrition in the pediatric population contributes to market growth.
• Regulatory Support and Guidelines: The establishment of guidelines and regulations by healthcare regulatory bodies and professional organizations promotes the safe and appropriate use of parenteral nutrition. These regulations ensure quality control, product safety, and standardization, fostering market growth.
• Increased Research and Development: Ongoing research and development activities focused on improving parenteral nutrition formulations, delivery methods, and addressing specific patient needs drive market growth. The development of specialized parenteral nutrition solutions tailored to specific patient populations and conditions further expands the market.

Future Opportunities Shaping the Parenteral Nutrition Market’s Evolution:

The parenteral nutrition market presents significant opportunities owing to the rising demand for specialized nutrition solutions across critical care, oncology, and neonatal care. With the global increase in cancer cases and gastrointestinal disorders, more patients are unable to meet their nutritional needs through oral or enteral feeding, creating a strong need for advanced parenteral nutrition. Developing economies, in particular, are witnessing growing healthcare infrastructure investments and awareness programs around malnutrition, opening avenues for wider adoption of parenteral nutrition therapies. Additionally, the trend toward personalized and disease-specific formulations provides opportunities for manufacturers to innovate and meet diverse clinical requirements.

Another major opportunity lies in the expansion of home-based parenteral nutrition (HPN) supported by advancements in infusion pumps, portable devices, and remote monitoring solutions. This shift reduces hospital stays, enhances patient quality of life, and lowers healthcare costs, driving broader acceptance of parenteral nutrition outside hospital settings. Furthermore, increasing collaborations between pharmaceutical companies and healthcare providers for clinical nutrition research, along with supportive regulatory frameworks for high-quality formulations, will accelerate market growth. Companies focusing on safer, more convenient, and cost-effective parenteral nutrition products are well-positioned to capitalize on these emerging opportunities.

Market Insights:

The global parenteral nutrition market is bifurcated into type, consumer type, end-user, and geography. On the basis of type, the market is further segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, and others. The single-dose amino acid solution segment dominated the global market in 2024 and expected to cover a major market share of over one-third percent of the market by 2030. The increasing adoption of the product due to the availability of various nutritional products such as vitamins, dextrose, and minerals is anticipated to drive the segment growth. In contrast, the parenteral lipid emulsion segment is accounted to grow at a fast growth rate over the forecast period.

The parenteral nutrition comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Parenteral Nutrition Market Segmentation:

By Type:

• Single Dose Amino Acid Solution
• Parenteral Lipid Emulsion
• Carbohydrates
• Trace Elements
• Vitamins & Minerals

By Consumer Type:

• Children & Newborns
• Adults

By End-User:

• Hospitals
• Clinics
• Home Care
• Other

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage: North America Leads the Parenteral Nutrition Market

Geographically, North America dominated the global parenteral nutrition market in 2024 and accounted to holds the largest market share of over one-third percent of the market. The technological advancement in healthcare and the increasing investment in research and development are some prominent factor to drive the market growth in the region. Furthermore, the increasing awareness regarding home healthcare products is anticipated to fuel the market in North America. On the other hand, the Asia Pacific is expected to grow at a fast growth rate over the forecast period.

Competition Assessment:

Some of the major players operating in the global parenteral nutrition market are Allergan plc, Amanta Healthcare Ltd, B. Braun Melsungen AG, Baxter International Inc., and Fresenius KABI AG. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Allergan plc
• Amanta Healthcare Ltd
• Braun Melsungen AG
• Baxter International Inc.
• Fresenius KABI AG
• Grifols International S.A.
• ICU Medical Inc.
• Otsuka Pharmaceutical Factory Inc.
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Sino-Swed Pharmaceutical Corp. Ltd.

Key Questions Answered by Parenteral Nutrition Market Report

• Global parenteral nutrition market forecasts from 2025-2030
• Regional parenteral nutrition market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2025-2030 covering 15 major countries from the aforementioned regions
• Parenteral nutrition submarket forecasts from 2025-2030 covering the market by type, by consumer type, by end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2025-2030
• Competitive Landscape and market positioning of top 10 players operating in the market